Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|
Revenue | $212.5M | $377.2M | $667.5M | $859.5M | $1,055.7M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, LifeStance Health Group, Inc.'s last 12-month Revenue is $1,206.1M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, LifeStance Health Group, Inc.'s Revenue growth was 20.1%. The average annual Revenue growth rates for LifeStance Health Group, Inc. have been 43.4% over the past three years, 75.2% over the past five years.
Over the last year, LifeStance Health Group, Inc.'s Revenue growth was 20.1%, which is higher than industry growth of 0.2%. It indicates that LifeStance Health Group, Inc.'s Revenue growth is Good.